Year: 2024
Type: article
Abstract: Introduction: In this study, we utilize the high-multiplex protein quantitation capability of Orion, and cell picking capability on CyteFinder, to perform a comprehensive liquid biopsy analysis of whole blood to identify circulating tumor cells (CTCs), large extracellular vesicles (LgEVs), and CTC-white blood cell hybrids; quantify protein biomarker expression on CTCs; perform immune profiling on white blood cells (WBCs); and perform targeted mutation profiling on CTCs and cell-free DNA (cfDNA) from plasma from 7.5 mL of blood.
Source: The Journal of Liquid Biopsy
Authors: Jon Ladd, Erin Bayer, Brock Bartels, Arista Tischner, Rachel Ponting, Jeff Chamberlain, Arturo B. Ramirez
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,080
OpenAlex ID: W4404581238
